CHARLES SCHWAB INVESTMENT MANAGEMENT INC - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 147 filers reported holding VIKING THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,472,092
+101.2%
765,320
+194.6%
0.00%
+100.0%
Q2 2023$4,210,418
+589.6%
259,742
+608.4%
0.00%
Q1 2023$610,522
+124.2%
36,668
+26.6%
0.00%
Q4 2022$272,280
+244.7%
28,9660.0%0.00%
Q3 2022$79,000
-38.8%
28,966
-34.9%
0.00%
Q2 2022$129,000
-78.1%
44,466
-77.4%
0.00%
Q1 2022$590,000
-27.7%
196,410
+10.8%
0.00%
Q4 2021$816,000
-24.5%
177,326
+3.0%
0.00%
Q3 2021$1,081,000
+5.2%
172,095
+0.3%
0.00%
Q2 2021$1,028,000
-2.4%
171,539
+3.1%
0.00%
Q1 2021$1,053,000
+20.5%
166,455
+7.3%
0.00%
Q4 2020$874,000
-3.4%
155,083
-0.2%
0.00%
Q3 2020$905,000
-22.3%
155,347
-3.8%
0.00%
-100.0%
Q2 2020$1,165,000
+48.0%
161,478
-4.0%
0.00%
Q1 2020$787,000
-40.5%
168,153
+1.9%
0.00%
-100.0%
Q4 2019$1,323,000
+18.3%
164,950
+1.6%
0.00%0.0%
Q3 2019$1,118,000
-9.3%
162,368
+9.5%
0.00%0.0%
Q2 2019$1,232,000
-8.0%
148,347
+10.2%
0.00%0.0%
Q1 2019$1,339,000
+35.4%
134,655
+4.2%
0.00%0.0%
Q4 2018$989,000
-49.0%
129,182
+16.0%
0.00%0.0%
Q3 2018$1,941,000
+121.8%
111,382
+20.9%
0.00%0.0%
Q2 2018$875,00092,1000.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Affinity Asset Advisors, LLC 622,249$10,360,4463.42%
GREAT POINT PARTNERS LLC 1,000,000$16,650,0003.27%
Ghost Tree Capital, LLC 600,000$9,990,0002.95%
SILVERARC CAPITAL MANAGEMENT, LLC 380,000$6,327,0002.61%
Integral Health Asset Management, LLC 727,100$12,106,2152.44%
Sio Capital Management, LLC 250,000$4,162,5002.06%
Boxer Capital, LLC 2,000,000$33,3001.64%
DAFNA Capital Management LLC 319,155$5,313,9311.59%
5AM Venture Management, LLC 350,000$5,827,5001.49%
Monashee Investment Management LLC 300,000$4,995,0001.38%
View complete list of VIKING THERAPEUTICS INC shareholders